DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
Clinical trial NCT00389779 · COMPLETED
Trial details
- NCT number
- NCT00389779
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2009-08-01
- Enrollment
- 849
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.